2 studies found for:    20951424 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience
Condition: Hepatitis C
Intervention: Drug: Sofosbuvir and simeprevir
2 Completed A Study of Combination Treatment With an HCV Polymerase Inhibitor (RO5024048) and an HCV Protease Inhibitor (RO5190591/Danoprevir) in Genotype 1 Chronic Hepatitis C Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: RO5024048;   Drug: danoprevir

Indicates status has not been verified in more than two years